Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...

Fecal microbiota transplant cut recurrent urinary tract infections by 68% in postmenopausal women and reduced ...

Over 660 million pilgrims gathered at the Maha Kumbh Mela in Prayagraj, India, this past February, and I'm now seeing the ...

Vaginal microbiome-drug interactions affect antibiotic treatment for bacterial vaginosis, emphasizing the need for ...

Scientists have studied a new target for antibiotics in the greatest detail yet – in the fight against antibiotic resistance.

Australia faces urgent warnings as the invasive New Zealand false widow spider spreads, posing dual threats through venomous ...

Iterum Therapeutics plc (Nasdaq: ITRM) ('Iterum” or the 'Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant ...

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

The most effective antipsychotic drug for people with treatment-resistant schizophrenia is clozapine. Yet, across the world, ...